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The Asian Dust Storm (ADS) aggravates symptoms and pulmonary dysfunction in adult 
asthma patients. Our objective was to investigate the association of air pollutants and metals 
in desert dust with worsening of asthma symptoms during the ADS. A telephone survey was 
performed to investigate the upper and lower respiratory tract symptoms, ocular symptoms 
and skin symptoms of asthma patients during the ADS in March between 2007 and 2010. 
Four surveys were conducted in 46 patients. Two patients noted worsening of lower respira-
tory tract symptoms in all four surveys, as well as 2 patients in three surveys, 7 patients in 
two surveys, and 9 patients in one survey. There was no worsening of lower respiratory tract 
symptoms in 26 patients. In each patient, the influence of the ADS on lower respiratory tract 
symptoms varied between surveys. In 2010, the level of suspended particulate matter was 
highest in all four years, but the smallest number of patients noted worsening of lower respira-
tory tract symptoms. Among pollutants, only the maximum concentration of nitrogen dioxide 
during the ADS was significantly associated with the worsening of lower respiratory tract 
symptoms. The influence of the ADS on lower respiratory tract symptoms of adult asthma pa-
tients is variable. 
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survey 
Dust storms originating in the deserts of Mongolia, 
northern China and Kazakhstan are collectively 
known as the Asian Dust Storm (ADS). It is a sea-
sonal phenomenon that affects much of East Asia, 
and the ADS occasionally even reaches the east 
coast of the United States (Duce et al., 1980; Taylor, 
2002). Recently, many studies have identified health 
problems related to the ADS, along with an increase 
in the frequency and duration of these storms (Han 
et al., 2004). In patients with asthma, some stud-
ies have found that exposure to the ADS increases 
hospitalization and emergency room visits, exacer-
bates symptoms, and impairs respiratory function 
(Kwon et al., 2002; Yoo et al., 2008; Kanatani et al., 
2010). Our previous studies have also revealed that 
the ADS is associated with deterioration of symp-
toms and respiratory function in adults with asthma 
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(Watanabe et al., 2011a, 2011b).
 Dust from deserts in Mongolia and northern 
China has been reported to cause pulmonary and 
bronchial inflammation in animals (Lei et al., 2004; 
Hiyoshi et al., 2005; Ichinose et al., 2006), but the 
mechanism through which the ADS causes exac-
erbation of asthma has not been fully clarified. In 
addition, the optimum methods for prevention and 
treatment of asthma attacks during ADS are not 
well understood. Aggravation of asthma symptoms 
during ADS may not be due to dust alone, because 
Asian desert dust contains natural and man-made 
metal components, fungi and lipopolysaccharide, 
and because the levels of various air pollutants 
such as SO and NO2 increase during ADS (Choi 
et al., 2001; Mori et al., 2003; Hong et al., 2010; 
Watanabe et al., 2011, in press). According to Hong 
et al. (2010), the concentrations of most of the met-
als bound to dust were significantly associated with 
a decrease of the peak expiratory flow rate (PEFR) 
in nonasthmatic school children, while the concen-
trations of particulate matter (PM) ≤ 2.5 μm and ≤ 
10 µm in diameter were not significantly associated 
with the PEFR. We previously reported that pol-
len combined with the ADS led to augmentation of 
symptoms and pulmonary dysfunction in patients 
with asthma (Watanabe et al., in press). 
 Between 2007 and 2011, we investigated 
whether patients with asthma experienced worsen-
ing of symptoms and pulmonary dysfunction dur-
ing ADS. The present study was performed to as-
sess the relations between asthma symptoms during 
ADS, and air pollutants and metals found in desert 
dust based on the results of our 4-year survey.
 
Materials and Methods
Patients
 
In each year between 2007 and 2010, we performed 
a telephone survey 3 days after the 1st ADS event 
and inquired whether asthma patients had experi-
enced exacerbation of upper and lower respiratory 
tract symptoms, ocular symptoms or skin symptoms 
(Watanabe et al., 2011a, 2011b). The present study 
focused on 46 asthma patients who participated in 
the telephone survey every March between 2007 
and 2010. Asthma was diagnosed according to the 
criteria in the Global Initiative for Asthma guide-
lines (GINA, 1995). All patients had a history of 
intermittent wheezing and airway hyperresponsive-
ness to methacholine or > 20% diurnal fluctuation 
of peak expiratory flow (PEF). They satisfied the 
definition of moderate asthma according to National 
Institute of Child Health and Human Development 
and the National Heart, Lung, and Blood Institute 
when assessed during February in every year of the 
survey (Schatz et al., 2003). Their inhaled cortico-
steroid dosages were classified as low, medium, or 
high according to the Japanese Guidelines for Al-
lergic Diseases (Japanese Society of Allergology, 
2011). All patients gave written informed consent.
Definition of the ADS and measurement of 
air pollutants, airborne pollen and metals
 
In Japan, ADS days are defined as days when visi-
bility is less than 10 km due to dust arising from the 
deserts of East Asia. In the present study, the ADS 
events were defined according to information pro-
vided by the Japan Meteorological Agency and the 
Ministry of the Environment. Suspended PM (SPM) 
and the levels of SO2, NO and NO2 were measured 
by Tottori Prefectural Institute of Public Health and 
Environmental Science. Natural and anthropogenic 
metal components such as Fe, Al, Ca, Cd, Mn, Ni, 
Cu, Pb and Cr, were also measured.
 Airborne pollen was measured with a Dur-
ham sampler placed on the roof of a building (10 m 
above ground level) at a location with free air move-
ment on all sides. Slides covered with glycerine jelly 
containing fuchin were exposed for 24 h. Then the 
pollen grains in an 18 × 18 mm area on each slide 
were counted after staining with Calbela’s solution. 
The total daily pollen count was expressed as the 
number of pollen particles/cm2.
 
 
 
Telephone survey 
 
As in our previous surveys (Watanabe et al., 2011a, 
2011b), we asked about the following symptoms 
during ADS days compared with a week before the 
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Table 1. Patient characteristics in 2007
 
Number 46
Age (yr) 63.4 ± 15.2
Gender (male/female) 23/23
Disease duration (mo) 109.3 ± 102.4
Presence of other allergic diseases
   Allergic rhinitis 22
       Cedar pollen and/or cypress pollen allergy 8
       Perennial allergic rhinitis  14
   Allergic conjunctivitis 2
   Atopic dermatitis 3
Non-allergic rhinitis 3
 
Data are presented as the mean ± SD.
ADS: i) worsening cough, sputum, wheezing, dys-
pnea and use of short-acting 2-agonists and hospi-
tal attendance for lower respiratory tract symptoms; 
ii) tearing, itching, mucus and pain as ocular symp-
toms; iii) stuffiness, sneezing, pharyngalgia and 
itching as upper respiratory tract symptoms and iv) 
itching, redness and pain as skin symptoms. We de-
fined exacerbation of symptoms as worsening of at 
least one symptom, but excluded patients who had 
confirmed or suspected respiratory tract infection. 
We defined respiratory tract infection as existing in 
any of the following patient groups: i) patients with 
pyrexia, trachyphonia, or sore throat; ii) patients 
who concluded that they had respiratory tract infec-
tion based on their own interpretation of symptoms 
and iii) patients whose family members and/or col-
leagues also had cold-related symptoms. 
 
Data analysis 
 
Results are shown as the mean ± SD. SPSS software 
(Japanese version 16.0 for windows; IBM Japan, To-
kyo, Japan) was used for statistical analysis. The 2 
test was employed to estimate differences between 
the surveys with respect to maintenance treatment, 
as well as differences in the frequency of patients 
with exacerbation of upper and lower respiratory 
tract symptoms, ocular symptoms, skin symptoms, 
and multiple classes of symptoms. Multivariate lo-
gistic regression analysis was performed to compare 
the effects of weather conditions, air pollutants, and 
maintenance treatment on deterioration of lower re-
spiratory tract symptoms during ADS. Significance 
was accepted at P < 0.05 for all analyses. The pres-
ent study was approved by the Ethics Committee 
of Tottori University (permission number: 771 and 
1082). All procedures were performed in accor-
dance with the principles defined in the Declaration 
of Helsinki. 
 
Results
Patient characteristics
 
Table 1 shows the characteristics of the patients in 
February in 2007. Forty-six patients (23 male and 
23 female) participated in the study. There were 22 
patients with allergic rhinitis, 3 with non-allergic 
rhinitis, 2 with allergic conjunctivitis and 3 with 
Table 2. Comparison of maintenance treatment during March in 
each year
 
 2007 2008 2009 2010
 survey survey survey survey
 
Inhaled corticosteroid 47 (100) 47 (100) 47 (100) 47 (100)
   Low dose 11 (23.9) 8 (17.4) 7 (15.2) 7 (15.2)
   Medium dose 18 (39.1) 18 (39.1) 14 (30.4) 15 (32.6)
   High dose 17 (37.0) 20 (43.5) 25 (54.3) 24 (52.2)
Long-acting 2-agonists 19 (41.3) 21 (45.7) 25 (54.3) 26 (56.5)
Leukotriene receptor antagonist 18 (39.1) 18 (39.1) 22 (47.8) 20 (43.5)
Teophylline 10 (21.7) 9 (19.6) 9 (19.6) 8 (17.4)
Antihistamine 5 (10.9) 6 (13.0) 8 (17.4) 8 (17.4)
Nasal corticosteroid* 0 (0) 1 (2.2) 6 (13.0) 10 (21.7)
 
 (  ), %.  
* P < 0.05: differences were estimated by the 2 test.
atopic dermatitis. In all of the 
telephone surveys, none of the 
patients complained of other al-
lergic diseases. Table 2 shows the 
maintenance treatment for asthma 
during March of each year. Use 
of intranasal corticosteroids in-
creased every year of the survey 
from no patients (0%) in 2007 to 1 
patient (2.2%) in 2008, 6 patients 
(13.0%) in 2009 and 10 patients 
(21.7%) in 2010. There were sig-
nificant differences between the 
surveys according to the 2 test. 
Apart from the use of intranasal 
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steroids, there were no significant differences of 
maintenance treatment between each survey. 
  
 
 
Air pollutants, airborne pollen and metal 
components 
Eight ADS days were identified during March 
between 2007 and 2010, including March 28 and 
29 in 2007; March 4 in 2008; March 16 and 17 in 
2009; and March 13, 16 and 21 in 2010. Table 3 
shows the daily average or maximum values for 
weather conditions, air pollutants, pollen and natu-
ral and man-made metals. SPM levels were high-
est in 2010, but airborne pollen levels were low on 
ADS days in 2010 (around 1/cm2/day). In contrast, 
pollen levels were high on ADS days in the other 
years, especially in 2009. The levels of air pollut-
ants (SO2, NO and NO2) and those of natural and 
anthropogenic metals varied widely. Most of the 
metal components identified were natural metals 
such as Fe, Al and Ca.
Telephone surveys
 
The results of the telephone surveys are displayed in 
Table 4. Worsening of lower respiratory tract symp-
toms was reported by 12 out of the 46 patients (26.1%) 
in the 2007 survey, 8 out of the 46 patients (17.4%) 
in the 2008 survey, 12 out of the 46 patients (26.1%) 
in the 2009 survey and 5 out of the 46 patients (10.9%) 
in the 2010 survey. The frequency of worsening 
symptoms did not differ significantly between the 
surveys. Worsening of upper respiratory tract symp-
toms was reported by 7 patients (15.2%) in 2007 
and 2008, 10 patients (21.7%) in 2009 and 1 patient 
(2.2%) in 2010, with a significant difference by the 
2 test. Worsening of ocular symptoms was reported 
by 4 out of the 46 patients (8.7%) in the 2007 survey, 
2 out of the 46 patients (4.3%) in the 2008 survey, 
9 out of the 46 patients (19.6%) in the 2009 survey 
and 1 out of the 46 patients (2.2%) in the 2010 sur-
vey. There were significant differences between the 
surveys by the 2 test. Although the SPM level was 
highest in 2010, the number of patients with worsen-
ing of upper respiratory tract and ocular symptoms 
was markedly lower than that in other years. None 
of the patients was hospitalized for exacerbation of 
asthma in any of the years investigated.
 Table 5 shows the number of patients with 
worsening of lower respiratory tract symptoms on 
ADS days across the four surveys. There were 9 
of the 46 patients with worsening of lower respira-
tory tract symptoms in only one survey, including 
2 patients in 2007, 5 patients in 2009 and 2 patients 
in 2010. All patients with deterioration of lower 
respiratory tract symptoms in 2008 also experi-
enced worsening of symptoms in other years. Seven 
patients had worsening of lower respiratory tract 
symptoms in two surveys, including 3 patients in 
both 2007 and 2008, 3 patients in both 2007 and 
Table 3. Weather conditions and concentration 
of air pollutants, air pollution levels, pollen, and 
natural and anthropogenic metal components on 
ADS day(s) in March of each year 
 
 March March March March
 29–30 4 16–17 21
 2007  2008  2009  2010 
 
Temperature*  (˚C) 12.9 6.3 15.0 9.2
Humidity*  (%) 72.0 78.0 50.3 60.6
Atmospheric 
   pressure*  (hPa) 1009.3 1011.0 1014.1 1015.3
SPM (mg/m3)
   Average  32.0 42.0 41.3 151.0
   Maximum  55.5 136.0 69.7 602.0
SO2  (ppb)
   Average  1.0 1.0 2.7 1.0
   Maximum  2.5 4.0 8.7 3.0
NO  (ppb)
   Average  3.0 2.0 1.0 0
   Maximum  9.5 6.0 3.3 1.0
NO2  (ppb)
   Average  10.0 6.0 7.0 5.0
   Maximum  26.5 21.0 25.0 17.0
Pollen  (/cm2/day) 46 20 165 1
Fe  (µg/m3) 2.4 2.0 7.6 16.7
Al  (µg/m3) 1.6 1.0 9.0 8.3
Ca  (µg/m3) 2.9 2.2 9.1 11.1
Cd  (µg/m3) 0.001 > 0.001 0.002 0.002
Mn  (µg/m3) 0.037 0.047 0.234 0.718
Ni  (µg/m3) 0.004 0.003 0.026 0.036
Cu  (µg/m3) 0.006 0.006 0.161 0.043
Cr  (µg/m3) 0.007 0.005 0.030 0.048
Pb  (µg/m3) 0.003 0.016 0.071 0.064
 
 ADS, Asian Dust Storm; SPM, suspended particulate 
matter. 
 Average, average concentration on ADS days; maxi-
mum, highest concentration on ADS days.
* Average.
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2009 and 1 patient in both 2008 
and 2009. Two patients had wors-
ening of lower respiratory tract 
symptoms in three surveys (2007, 
2008, 2009 for 1 patient and 2007, 
2008, 2010 for another). Finally, 2 
patients noted worsening of their 
lower respiratory tract symptoms 
in all four surveys. Even in the 
same patient, the influence of 
ADS on lower respiratory tract 
symptoms often varied widely. 
Twenty-six out of the 46 patients 
(56.5%) did not complain of wors-
ening of lower respiratory tract 
symptoms throughout the four 
surveys (Table 6), and 22 patients 
(47.8%) did not have worsening of 
any symptoms on ADS days.
 Multiple logistic regression 
analysis using the forward selec-
tion method and calculation of the 
likelihood ratio was performed 
to investigate the association of 
worsening of lower respiratory 
tract symptoms with air pollutants, 
Table 4. Results of the annual telephone surveys
 
 2007 2008 2009 2010
 survey survey survey survey
 
Patients with any symptoms 33 (71.7) 35 (76.1) 31 (67.4) 40 (87.0)
Patients with worsening of 
    either symptom 14 (30.4) 12 (26.1) 16 (34.8) 7 (15.2)
Patients with worsening of 
   lower respiratory tract symptom 12 (26.1) 8 (17.4) 12 (26.1) 5 (10.9)
       Cough 9 (19.6) 7 (15.2) 8 (17.4) 4 (8.7)
       Sputum 8 (17.4) 4 (8.7) 8 (17.4) 3 (6.5)
       Wheezing 1 (2.2) 1 (2.2) 4 (8.7) 0 (0)
       Dyspnea 5 (10.9) 5 (10.9) 5 (10.9) 1 (2.2)
Patients with worsening of 
   upper respiratory tract symptom* 7 (15.2) 7 (15.2) 10 (21.7) 1 (2.2)
       Sneezing 6 (13.0) 6 (12.8) 7 (15.2) 0 (0)
       Stuffiness 2 (4.3) 2 (4.3) 3 (6.5) 1 (2.2)
       Itching 0 (0) 1 (2.2) 0 (0) 0 (0)
Patients with worsening of 
   ocular symptom* 4 (8.7) 2 (4.3) 9 (19.6) 1 (2.2)
       Tearing 1 (2.2) 0 (0) 0 (0) 1 (2.2)
       Itching 3 (6.5) 2 (4.3) 9 (19.6) 0 (0)
       Mucus  1 (2.2) 0 (0) 1 (2.2) 1 (2.2)
       Pain 0 (0) 0 (0) 0 (0) 0 (0)
Patients with worsening of 
    skin symptom 0 (0) 0 (0) 0 (0) 0 (0)
Hospitalization for 
    exacerbation of asthma 0 (0) 0 (0) 0 (0) 0 (0)
 
 (  ), %.  
* P < 0.05: the 2 test was used to assess differences among the surveys in the 
frequency of patients with worsening of any symptoms, upper or lower respi-
ratory tract symptoms, ocular symptoms or skin symptoms. 
Table 5. Patients with worsening of lower respira-
tory tract symptoms on ADS days in each survey
 Number
2007 survey 2
2008 survey  0
2009 survey 5
2010 survey 2
2007 and 2008 survey 3
2007 and 2009  survey 3
2007 and 2010 survey 0
2008 and 2009 survey 1
2008 and 2010 survey 0
2009 and 2010 survey 0
2007, 2008 and 2009 survey 1
2007, 2008 and 2010 survey 1
2007, 2009 and 2010 survey  0
2008, 2009 and 2010 survey 0
2007, 2008, 2009 and 2010 survey 2
ADS, Asian Dust Storm. 
Nine patients had worsening of lower respiratory tract symp-
toms on ADS days in one survey as well as 7 patients in two 
surveys, 2 patients in three surveys and 2 patients in all four 
surveys.
pollen, metal components and maintenance therapy 
for asthma (Table 7). As a result, worsening of 
lower respiratory tract symptoms was significantly 
associated with the maximum hourly concentration 
of NO2 on ADS days and the daily dose of inhaled 
corticosteroids, but not with the levels of SPM, pol-
len, SO2, NO and natural or anthropogenic metal 
components.
 
 
Discussion
 
The present study showed that the influence of ADS 
on lower respiratory tract symptoms, upper respira-
tory tract symptoms, ocular symptoms and skin 
symptoms was often different for each ADS day in 
patients with asthma. Only 4% of the patients con-
sistently showed exacerbation of lower respiratory 
tract symptoms on every ADS day. Also, 48% of 
the patients were completely unaffected by the ADS 
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and worsening of symptoms was unrelated to the 
SPM level, suggesting that other factors may have 
aggravated the symptoms of asthma patients in ad-
dition to Asian dust.
 We previously reported that some asthma 
patients had worsening of lower respiratory tract 
symptoms on ADS days and that pollen augmented 
the influence of ADS on symptoms (Watanabe et 
al., 2011a, 2011b). Dust from deserts in Mongolia 
and northern China has been found to exacerbate 
pulmonary and bronchial inflammation in animals 
(Let et al., 2004; Hiyoshi et al., 2005; Ichinose et al., 
2006). However, it was not clear that the worsening 
of symptoms on ADS days was only due to desert 
dust, because the levels of anthropogenic metals 
(such as Cd, Mn and Ni) and SO2 were significantly 
higher on ADS days than non-ADS days in Tottori 
(Watanabe et al., 2011a, 2011b). It has been reported 
that Cd, Mn, Ni and SO2 can induce airway inflam-
mation and/or bronchoconstriction (Lazarus et al., 
1997; Lison et al., 1997; Gavett et al., 2003; Zhang 
et al., 2003; Jakubowski et al., 2004; Liu et al., 
2009). 
 Our previous study revealed that the daily PEF 
was significantly associated with the SPM level in 
patients with worsening of upper and/or lower re-
spiratory tract symptoms during ADS (Watanabe et 
al., 2011). In contrast, the present study showed that 
the influence of ADS on asthma symptoms varied 
even in the same patient. In 2010, the SPM level was 
the highest among all four surveys, but the smallest 
percentage of patients with exacerbation of lower 
respiratory tract symptoms was found in the 2010 
survey. It is known that SO2 itself induces airway 
inflammation and/or bronchoconstriction (Lazarus 
et al., 1997). Therefore, our findings suggest that the 
worsening of lower respiratory tract symptoms dur-
ing ADS was not only due to desert dust.
 According to Hong et al. (2010), exposure to 
metals bound to dust particles during ADS reduced 
the pulmonary function of children, but we could 
not find any association between worsening of low-
er respiratory tract symptoms in asthma patients on 
ADS days and the levels of natural and/or anthro-
pogenic metals. In this study, the maximum con-
centration of NO2 was significantly associated with 
worsening of lower respiratory tract symptoms ac-
cording to multiple logistic regression analysis, but 
the levels of metals did not show any association. 
Many studies have indicated that NO2 is associated 
with airway inflammation and bronchoconstriction 
in asthma patients after even short-term exposure 
(Mann et al., 2010; Di Giampaolo et al., 2011). Ac-
cordingly, the deterioration of lower respiratory 
tract symptoms during ADS in asthma patients was 
probably not only related to dust, but also to other 
air pollutants such as NO2.
 The results of our study differed from those 
of Hong et al. (2010) possibly because the levels of 
PM and metal components during ADS are lower 
Table 7. Adjusted odds ratio for the influence of weather conditions, air pollutants, maintenance treat-
ment on worsening of lower respiratory tract symptoms during ADS (multiple logistic regression 
analysis)
 Partial regression Odds  95%  P value
 coefficient ratio confidence interval
NO2 (maximum) 0.135 1.15 1.008–1.248 < 0.05
Daily dosage of inhaled corticosteroids 0.801 2.23 1.252–3.969 < 0.01
ADS, Asian Dust Storm. 
NO2 (maximum) is the maximum hourly concentration of NO2 on ADS days. 
Table 6. Patients without worsening of symp-
toms on ADS days in any survey
 Number (%)
Patients without worsening of 
   any symptoms  22 (47.8)
Patient without worsening of 
   lower respiratory symptoms  26 (56.5)
ADS, Asian Dust Storm. 
Four patients did not experience of worsening of lower re-
spiratory tract symptoms, but had worsening of upper respi-
ratory tract symptoms or ocular symptoms.  
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in Tottori than in Korea. However, the most im-
portant difference may be related to the age of the 
subjects. Some studies reported an increased risk of 
hospitalization during ADS in children with asthma 
(Kanatani et al., 2010; Ueda et al., 2010), so the 
influence of ADS or other air pollutants may differ 
between adults and children. According to Devalia 
et al. (1994), exposure to a combination of SO2 and 
NO2 enhances the airway response to inhaled aller-
gens compared with the effect of SO2 or NO2 alone 
in patients with asthma. Thus, allergens may induce 
bronchoconstriction more easily on ADS days than 
non-ADS days, because SO2 levels were signifi-
cantly higher on ADS days than non-ADS days in 
Tottori (Watanabe et al., 2011b).
 A higher daily dosage of inhaled corticoste-
roids was also a risk factor for deterioration of lower 
respiratory tract symptoms during ADS. If patients 
need high doses of inhaled corticosteroids to control 
asthma, their airway inflammation may not be fully 
suppressed even though they were classified as hav-
ing moderate asthma. This means that desert dust 
and/or air pollutants could readily induce broncho-
constriction and aggravate airway inflammation in 
patients on high-dose inhaled corticosteroids. 
 In this study, 22 of the 46 patients (47.8%) also 
had allergic rhinitis and 3 of the 46 patients (6.5%) 
had non-allergic rhinitis. However, the ratio of use 
of antihistamines was below 18%, and that of nasal 
corticosteroids were below 22% through the four 
surveys. Especially in 2007 and 2008, the number 
of patients using intranasal steroids was 0 and 1, re-
spectively. Thus, the asthma patients with rhinitis in 
this study may have had poorly controlled rhinitis, 
although leukotriene receptor antagonists were used 
by 39.1% to 47.8%. In patients with rhinitis, dry air 
and PM can easily reach the lower airways, because 
the ability of the nasal passages to warm and hu-
midify air is impaired (Ingelstedt and Ivstam, 1951; 
Togias, 2003). To prevent the exacerbation of lower 
respiratory tract symptoms on ADS days in asthma 
patients using high-dose inhaled corticosteroids, 
treatment of upper airway conditions may be more 
beneficial than more intensive therapy for asthma.
  In conclusion, the influence of ADS on the 
symptoms of asthma patients differed between sur-
veys, even in the same patient. The reason for this 
finding may be differences in the levels of natural or 
anthropogenic metals air pollutants, and pollen on 
each ADS day. The level of NO2 was significantly 
associated with the exacerbation of lower respirato-
ry tract symptoms during ADS, and the dust storms 
had more influence on symptoms in patients using 
higher daily doses of inhaled corticosteroids whose 
asthma may have been poorly controlled. The des-
ert dust itself may influence airway inflammation 
in Japanese asthma patients, but further studies are 
needed to define the role of other air pollutants and 
materials bound to the dust such as natural and an-
thropogenic metals.
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